NCT04288375 - Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Soft Tissue Sarcoma

Interventions

RADIATION

Intensity-modulated radiation therapy (IMRT)

The prescribed dose of radiations for all patients will be 50 Gy in 25 fractions. 6MV energy photons will be used. Multi-beam IMRT plans, utilizing dynamic multileaf collimation, will be created based on the target tissue coverage and normal tissue avoidance.

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (All protocol activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (All protocol activities), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Commack (All protocol activities), Commack

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (All protocol activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (All protocol activities), Montvale

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER